This bill (SF 2422) amends Iowa's eligibility rules for the Supplemental Nutrition Assistance Program (SNAP), Medicaid, and the Iowa Health and Wellness Plan. It requires verification of U.S. citizenship or immigration status using the federal Systematic Alien Verification for Entitlements (SAVE) system before approving SNAP benefits, defining "alien" as anyone not a U.S. citizen or national. The bill also limits retroactive Medicaid eligibility to pregnant women, children, and nursing facility residents (for up to two months prior to application), while prohibiting retroactive coverage for other adults. These changes directly affect Iowa residents applying for food assistance or medical aid who are non-citizens or seeking retroactive benefits.
This Iowa bill establishes new rules for abortions, specifically requiring doctors to perform in-person examinations to screen for coercion before any procedure and mandating detailed informed consent for drug-based abortions. Under the new provisions, physicians must obtain a patient's signature on a federal form and provide written warnings about specific medical risks, including potential hemorrhage, sterility, and the possibility of the pregnancy continuing. The legislation also restricts the dispensing of abortion-inducing drugs to licensed healthcare settings and creates a private civil lawsuit allowing individuals to sue providers who violate these dispensing rules, while protecting the identity of women involved in such cases. Additionally, the bill defines "pregnancy" as beginning at fertilization and clarifies that these requirements do not apply in cases of medical emergencies.
HF 571, the "Medical Ethics Defense Act," protects medical practitioners, healthcare institutions, and health care payors from discrimination when refusing to provide or cover specific services based on conscience (e.g., religious or ethical beliefs). It prohibits adverse actions like termination or penalties for such refusals, requires health care payors to cover services they’re contractually obligated to pay for, and grants immunity from liability for good-faith conscience-based decisions. The bill also shields whistleblowers who report violations related to conscience protections or ethical violations to authorities like the attorney general or federal agencies. It explicitly does not override requirements for emergency care under federal law.
Senate File 304 amends existing law concerning a minor's ability to consent to medical care related to sexually transmitted diseases (STDs). Currently, minors can independently consent to medical care or services for the prevention, diagnosis, or treatment of STDs. This bill introduces a specific exception to that provision. Under SF 304, a minor will no longer have the legal capacity to consent to the provision of a vaccination for a sexually transmitted disease or infection without the consent of another person, such as a parent or guardian.
This bill creates a new health care-related tax on health maintenance organizations operating in Iowa, requiring them to pay 0.95% of their taxable funds to a newly established Medicaid managed care organization premiums health care tax fund. The tax applies to payments received from enrollees for health care services and benefits, while excluding certain federal payments, and includes provisions for prepayment, credit refunds, and enforcement measures like license suspension for nonpayment. Additionally, the legislation appropriates funds from the taxpayer relief fund and supplements appropriations to the Department of Health and Human Services, with specific effective dates and retroactive applicability provisions included.
SF 615 adds work requirements for participants in Iowa's health and wellness plan and Medicaid for employed people with disabilities, directly affecting eligible residents receiving these specific public assistance benefits. The bill requires individuals to meet certain work or training hours to maintain eligibility, alongside provisions for related funding mechanisms like the information technology fund and public assistance modernization fund. It became law after the Governor signed it on June 6, 2025, implementing these new eligibility conditions for the specified programs. The policy change modifies existing program rules without altering benefit amounts or creating new programs.
HF 972, now law after Governor's signature on May 28, 2025, establishes a new funding model for Iowa's rural healthcare systems while eliminating several existing health care programs. It removes specific award, grant, residency, and fellowship programs, and creates a new incentive program to attract healthcare professionals to underserved areas. The bill also modifies Medicaid funding for graduate medical education, updates the Health Facilities Council, and addresses the Iowa Health Information Network, with all changes including necessary funding appropriations. These changes directly affect rural health providers, medical training programs, and state health agencies managing these systems.
HF 516 creates priority access for residency and fellowship positions at the University of Iowa’s colleges of medicine and dentistry, directly affecting UI’s medical programs and their affiliated hospitals and clinics. The bill requires state-funded training programs to prioritize applicants from these UI institutions when filling medical residency and fellowship roles. Now law after Governor signed it on June 11, 2025, this policy change aims to strengthen UI’s medical education pipeline without altering broader admission standards for other institutions.
SF 383 requires pharmacy benefits managers (PBMs) to disclose drug pricing details and standardized fee structures to pharmacies and insurers. It limits certain PBM practices that affect prescription drug costs and establishes transparency rules for pharmacy services administrative organizations. The law directly affects PBMs, pharmacies, and insurance companies managing prescription drug benefits. Signed into law by the Governor on June 6, 2025, it aims to increase transparency in drug pricing and pharmacy billing.
